Phesgo Patient Assistance Program

(pertuzumab, trastuzumab, and hyaluronidase-zzxf)

Key Takeaways

  1. Phesgo® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a subcutaneous biologic medication used for adults with HER2-positive breast cancer in specific early-stage and metastatic treatment settings.
  2. Pertuzumab and trastuzumab target different areas of the HER2 receptor, helping block signals involved in cancer-cell growth and survival. Hyaluronidase-zzxf temporarily increases tissue permeability so the antibody combination can be administered under the skin rather than through an intravenous infusion.
  3. Phesgo may be used before surgery with chemotherapy, after surgery for certain patients at high risk of recurrence, or with docetaxel for certain patients with HER2-positive metastatic breast cancer. HER2 testing is required before treatment.
  4. Prescription Hope may be able to help patients needing access to the Phesgo patient assistance program.

 

Introduction

Breast cancer treatment can involve specialized medications, multiple treatment phases, and high costs. Phesgo is a HER2-targeted biologic used in specific treatment settings for adults with HER2-positive breast cancer.

Phesgo combines pertuzumab and trastuzumab, two monoclonal antibodies that target different portions of the HER2 receptor. Together, they interfere with HER2 signaling and can help the immune system recognize and attack HER2-overexpressing cancer cells. Hyaluronidase-zzxf allows the medication to be delivered as a subcutaneous injection.

Because Phesgo is a specialty oncology biologic, treatment costs can vary considerably. Insurance coverage, deductibles, coinsurance, treatment setting, number of cycles, and assistance eligibility can all affect what a patient pays.

Prescription Hope provides medication assistance support for eligible patients seeking more affordable access to prescription medications. Understanding available assistance options can be an important part of managing the financial side of cancer treatment.

What Is the Phesgo Patient Assistance Program?

Understanding Phesgo Prescription Assistance

Patients needing more affordable Phesgo often must seek out alternative savings options due to lack of insurance coverage or high out-of-pocket expenses.

The Phesgo patient assistance program may help.

Pharmaceutical manufacturers understand that not all brand-name medications are affordable at retail prices. To help struggling patients, manufacturers often provide patient assistance programs.

Through these, qualified patients get access to their brand-name medication at affordable rates – often at low to no cost.

However, patient assistance programs have a reputation for extremely complex application processes that leave patients feeling stressed or overwhelmed.

Prescription Hope can help.

How Expert Advocates Help Make Phesgo More Affordable

Personalized Medication Assistance

Those needing breast cancer medication assistance may benefit from Prescription Hope’s Phesgo cost support access service.

Our team of patient advocates supports you throughout the patient assistance program application process. They complete forms, collect and organize documents, gather signatures from healthcare providers, coordinate with manufacturers, advocate on your behalf through red tape and bureaucracy, and more.

Ongoing Patient Support

But our team doesn’t stop after your initial shipment of Phesgo arrives. Prescription Hope continues to manage the administrative tasks associated with patient assistance programs.

We handle refill scheduling, document updates, issue resolution, yearly renewals, and more.

All for a low, simple monthly service rate.

Phesgo Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$9,477.78

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Treatment Costs

Those needing help paying for Phesgo and looking to lower their Phesgo cost may benefit from Prescription Hope’s services. Our rate of $70.00 per month, per medication provides all services and advocacy without any hassles, hidden fees, or medication costs.

Phesgo Patient Assistance Eligibility

General Eligibility Requirements

Those curious about Phesgo patient assistance eligibility may be interested in knowing more about the patient assistance program eligibility requirements.

While each program has unique specific requirements, all programs use several general categories to determine qualification. Some of those categories include:

Income: Each program sets its own income range for qualification.

Insurance: Some programs require patients to have no insurance, while others allow some form of insurance.

Prescription: Every program requires qualified patients to have a valid prescription for the medication they’re applying for.

Residency: All programs require qualified patients to be legal U.S. residents.

Simple Enrollment With Expert Support

Getting Started With Enrollment

If you’re looking to get started with your Phesgo patient assistance application, then be sure to start your enrollment with Prescription Hope today. Our 6-step process includes:

  1. Submit Information: Complete our online form in a matter of a few minutes.
  2. Advocate Contact: A patient advocate will reach out within 1-2 business days.
  3. Document Collection: Following a quick prequalification, our team will collect all necessary documents and complete needed forms.
  4. Provider Coordination: We also communicate with your healthcare provider to get needed signatures.
  5. Application Submission: Once your application is prepared, we submit the entire packet and follow up with the manufacturer throughout the processing stage.
  6. Medication Delivery: Once approved, qualified patients typically receive their medication within 2 weeks. All medication ships directly from the manufacturer to the patient’s door or doctor’s office.

Please note that Prescription Hope is not a pharmacy or manufacturer and therefore does not handle medication at any time. All medication shipments are therefore the manufacturer’s responsibility.

Understanding Phesgo

How Phesgo Works

Phesgo combines pertuzumab, trastuzumab, and hyaluronidase-zzxf.

Pertuzumab and trastuzumab both target HER2, but they bind to different portions of the receptor. Pertuzumab interferes with HER2’s ability to form signaling partnerships with other HER family receptors, while trastuzumab blocks HER2 signaling and can help immune cells recognize HER2-overexpressing cancer cells.

Hyaluronidase-zzxf temporarily increases permeability in the tissue beneath the skin, allowing antibodies to be absorbed following subcutaneous injection.

In simple terms, Phesgo uses two complementary antibodies to interfere with HER2-driven cancer activity while hyaluronidase makes subcutaneous administration possible.

What Conditions Does Phesgo Treat?

Phesgo is FDA-approved for adults with HER2-positive breast cancer in specific treatment settings.

These include:

  • HER2-positive locally advanced, inflammatory, or certain early-stage breast cancers before surgery, in combination with chemotherapy
  • HER2-positive early breast cancer after surgery in patients at high risk of recurrence
  • HER2-positive metastatic breast cancer, in combination with docetaxel, when patients have not previously received anti-HER2 therapy or chemotherapy for metastatic disease

HER2 testing using an FDA-authorized breast cancer test is required for patient selection.

Phesgo is therefore not a treatment for breast cancer generally; its approved uses specifically involve HER2-positive disease.

Benefits of Treatment

For appropriately selected adults with HER2-positive breast cancer, Phesgo may:

  • Slow or destroy HER2-positive cancer cells
  • Reduce cancer remaining before surgery
  • Reduce the risk of recurrence in appropriate early breast cancer
  • Help control metastatic breast cancer
  • Provide pertuzumab and trastuzumab through subcutaneous injection
  • Reduce administration time compared with intravenous administration

Important Safety Information and Side Effects

Phesgo carries an FDA Boxed Warning for cardiomyopathy, embryo-fetal toxicity, and pulmonary toxicity.

Cardiomyopathy and Heart Failure

Phesgo can cause decreased left ventricular ejection fraction and heart failure.

Potential complications include:

  • Congestive heart failure
  • Symptomatic cardiac dysfunction
  • Cardiomyopathy
  • Potentially fatal cardiac events

Cardiac function should be evaluated before and during treatment. Risk can be greater when Phesgo is administered with anthracycline-containing chemotherapy.

Embryo-Fetal Toxicity

Phesgo can cause fetal harm, including fetal death and birth defects.

Important considerations include:

  • Verify pregnancy status before treatment in females of reproductive potential
  • Use effective contraception during treatment
  • Continue contraception for 7 months after the final dose
  • Contact a healthcare provider promptly if pregnancy occurs during treatment or within seven months afterward

Pulmonary Toxicity

Phesgo can cause serious or potentially fatal pulmonary complications, including:

  • Interstitial pneumonitis
  • Pulmonary infiltrates
  • Pleural effusion
  • Pulmonary edema
  • Pulmonary insufficiency
  • Hypoxemia
  • Acute respiratory distress syndrome
  • Pulmonary fibrosis

Chemotherapy-Induced Neutropenia

Phesgo may worsen neutropenia caused by chemotherapy.

Potential concerns include:

  • Neutropenia
  • Febrile neutropenia
  • Increased infection risk

Blood counts may be monitored during treatment.

Hypersensitivity and Administration-Related Reactions

Serious reactions can occur during or following administration, including:

  • Anaphylaxis
  • Angioedema
  • Difficulty breathing
  • Fever
  • Chills
  • Nausea
  • Vomiting
  • Diarrhea
  • Hives
  • Chest pain
  • Dizziness

Patients are observed after injections for potential administration-related reactions.

Common Side Effects

For early breast cancer treatment, commonly reported adverse reactions include:

  • Hair loss
  • Nausea
  • Diarrhea
  • Anemia
  • Asthenia
  • Fatigue
  • Constipation
  • Vomiting
  • Stomatitis
  • Rash
  • Muscle pain
  • Joint pain
  • Peripheral neuropathy
  • Injection-site reactions

For metastatic breast cancer, commonly reported reactions include:

  • Diarrhea
  • Hair loss
  • Neutropenia
  • Nausea
  • Fatigue
  • Rash
  • Peripheral neuropathy

Contraindications

Phesgo is contraindicated in patients with a known severe hypersensitivity to:

  • Pertuzumab
  • Trastuzumab
  • Hyaluronidase
  • Any component of the formulation

Important Treatment Considerations

Phesgo should not be substituted for intravenous pertuzumab, intravenous trastuzumab, ado-trastuzumab emtansine, or fam-trastuzumab deruxtecan. These products have different formulations, indications, doses, and administration instructions.

Patients receiving anthracycline chemotherapy may require particular consideration because of the potential for cardiac dysfunction.

Pregnancy and Breastfeeding

No adequate human data establishes whether Phesgo is present in human milk or how its components affect a breastfed child.

Patients should discuss breastfeeding with their healthcare provider, considering the mother’s clinical need for treatment and potential risks to the infant.

Access to Multiple Medications

Support Beyond Phesgo

Prescription Hope provides much more than breast cancer medication assistance services. With hundreds of available medications, many patients qualify for several patient assistance programs through Prescription Hope.

Whether one or many, our services are all included in our rate of $70.00 per month, per medication.

Why Choose Prescription Hope for Phesgo Assistance

Patient-Focused Medication Support

After two decades, Prescription Hope continues to provide excellence in support, service, and advocacy. Our patients enjoy knowing our team is there every step of the way and handles the application process from start to finish.

Simplified Access to Specialty Therapies

Sadly, breast cancer treatment takes a toll on both the patient and their loved ones. With complicated prescriptions, visits to healthcare professionals, and expensive bills, people dealing with breast cancer can feel overwhelmed.

Prescription Hope doesn’t just offer access to specialty therapies. Our team offers support and advocacy for your medication journey. All of our services are included in the $70.00 per month, per medication service fee. Yet, our patients never have to deal with hidden fees, variable pricing systems, hassles, or even medication costs.

$70.00 per month, per medication. That’s it.

Ongoing Prescription Assistance

After the initial shipment arrives, our patients continue to enjoy our enrollment management services.

Patients don’t need to worry about the red tape or administrative tasks associated with maintaining their enrollment. Instead, our team handles refill scheduling, document updates, issue resolution, program monitoring, and yearly renewals.

If you’re looking for Phesgo and ready to enroll in the Phesgo patient assistance program, then be sure to fill out Prescription Hope’s online enrollment form today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!